Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of interleukin 13 in classical Hodgkin lymphoma.
Skinnider BF, Kapp U, Mak TW. Skinnider BF, et al. Leuk Lymphoma. 2002 Jun;43(6):1203-10. doi: 10.1080/10428190290026259. Leuk Lymphoma. 2002. PMID: 12152987 Review.
Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo.
Trieu Y, Wen XY, Skinnider BF, Bray MR, Li Z, Claudio JO, Masih-Khan E, Zhu YX, Trudel S, McCart JA, Mak TW, Stewart AK. Trieu Y, et al. Among authors: skinnider bf. Cancer Res. 2004 May 1;64(9):3271-5. doi: 10.1158/0008-5472.can-03-3764. Cancer Res. 2004. PMID: 15126369
Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U, Mak TW. Skinnider BF, et al. Blood. 2002 Jan 15;99(2):618-26. doi: 10.1182/blood.v99.2.618. Blood. 2002. PMID: 11781246
The role of cytokines in classical Hodgkin lymphoma.
Skinnider BF, Mak TW. Skinnider BF, et al. Blood. 2002 Jun 15;99(12):4283-97. doi: 10.1182/blood-2002-01-0099. Blood. 2002. PMID: 12036854 Review.
Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF, Elia AJ, Gascoyne RD, Trümper LH, von Bonin F, Kapp U, Patterson B, Snow BE, Mak TW. Skinnider BF, et al. Blood. 2001 Jan 1;97(1):250-5. doi: 10.1182/blood.v97.1.250. Blood. 2001. PMID: 11133768
Interleukin 13: a growth factor in hodgkin lymphoma.
Skinnider BF, Kapp U, Mak TW. Skinnider BF, et al. Int Arch Allergy Immunol. 2001 Dec;126(4):267-76. doi: 10.1159/000049523. Int Arch Allergy Immunol. 2001. PMID: 11815733 Review.
Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.
Zhou M, Fadlelmola FM, Cohn JB, Skinnider B, Gascoyne RD, Banerjee D. Zhou M, et al. Mol Cancer. 2008 Jan 24;7:12. doi: 10.1186/1476-4598-7-12. Mol Cancer. 2008. PMID: 18218123 Free PMC article.
Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma.
Brooks EG, Connors JM, Sehn LH, Gascoyne RD, Savage KJ, Shenkier TN, Klasa R, Gerrie AS, Skinnider B, Slack GW, Villa D. Brooks EG, et al. Leuk Lymphoma. 2016;57(4):872-9. doi: 10.3109/10428194.2015.1086919. Epub 2015 Oct 13. Leuk Lymphoma. 2016. PMID: 26325236
CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma.
Wilson KS, Sehn LH, Berry B, Chhanabhai M, Fitzgerald CA, Gill KK, Klasa R, Skinnider B, Sutherland J, Connors JM, Gascoyne RD. Wilson KS, et al. Leuk Lymphoma. 2007 Jun;48(6):1102-9. doi: 10.1080/10428190701344881. Leuk Lymphoma. 2007. PMID: 17577773
Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis.
Xing KH, Connors JM, Lai A, Al-Mansour M, Sehn LH, Villa D, Klasa R, Shenkier T, Gascoyne RD, Skinnider B, Savage KJ. Xing KH, et al. Blood. 2014 Jun 5;123(23):3567-73. doi: 10.1182/blood-2013-12-541078. Epub 2014 Apr 8. Blood. 2014. PMID: 24713929
27 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page